WO2013016743A1 - Dispositif et procédé pour une analyse rapide et précise de fluides corporels - Google Patents

Dispositif et procédé pour une analyse rapide et précise de fluides corporels Download PDF

Info

Publication number
WO2013016743A1
WO2013016743A1 PCT/ZA2012/000014 ZA2012000014W WO2013016743A1 WO 2013016743 A1 WO2013016743 A1 WO 2013016743A1 ZA 2012000014 W ZA2012000014 W ZA 2012000014W WO 2013016743 A1 WO2013016743 A1 WO 2013016743A1
Authority
WO
WIPO (PCT)
Prior art keywords
cells
filter
pap
analysis
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ZA2012/000014
Other languages
English (en)
Inventor
Constance Wilson ANDRESEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA2011/05403A external-priority patent/ZA201105403B/en
Application filed by Individual filed Critical Individual
Publication of WO2013016743A1 publication Critical patent/WO2013016743A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis

Definitions

  • the invention relates to device and method for rapid and accurate bodily fluid analysis.
  • the current Pap test requires the gynaecologist to take a specimen by scraping or smear from the cervix, using a spatula or swab and rubbing the material onto a slide.
  • the slide is sprayed with a fixative to preserve the specimen and is then transported to the lab.
  • the specimen is then placed into a slide holder (along with many other slides - as many as twenty or more, and from any other patients, and dipped either by hand or by automatic dipping machine into the various Pap Test solutions (approximately 18) each of which is contained in its own vessel.
  • the vessels used are small, usually glass, and usually rectangular tubs.
  • the issued Andresen Patent Nos. 5 247 941 and 5 327 897 describes a method for collection and analyzing blood by introducing into a cavity of the person, for example the vagina in the case of a woman, of a device which has an interior capable of receiving and holding blood which is present in the cavity.
  • the device may be a tampon inserted by a woman into the vagina for collecting the blood during menstrual flow.
  • the blood thus collected can be subjected to analysis, for example Pap Rest analysis.
  • This method and device for collecting blood as set forth in the Andresen Patent Nos. 5 247 941 and 5 327 847 provide a greater accuracy for analysis than does the ordinary Pap smear or scrapping test.
  • the very simplicity of the method and device of the Andresen patents leads to the problem of a need for a more rapid and possibly automated analysis system as described because the method and device do not require the gynaecologist or nurse examiner, and the laboratories would be flooded with collections that would be requiring analysis. Still further, greater accuracy of analysis is required and will lead to better results because of the large number of collections obtained for analysis.
  • the present invention mainly comprises a method of analysis of menstrual blood flow wherein menstrual blood collected by a tampon or the like, which blood would include cells of clinical interest, is deposited in a container provided with a filter having a pore size such that all cells of clinical interest in the blood specimen cannot pass through the filter while cells which are not of clinical interest, for example red and white blood cells are small enough to pass through the filter, subjecting the menstrual blood in the container to washings and back washings, for example with saline solution or balanced salt solution, e.g. Ringer's solutions, and further subjecting the suspended cells to the approximately 18 Pap solutions after which the cells remaining in the container may be deposited on a glass slide and analyzed by the cytologist.
  • the analysis may be by way of standard slide examination or utilizing computers.
  • the filter used in the container of the invention is preferably a 12-micron pore size filter.
  • Cells of clinical interest are substantially larger than 25 microns and cannot go through the pores of the filter.
  • the cells that are not of clinical interest for example red and white blood cells which have a size of about 7 microns, are small enough to go through the filter pores and are removed from the specimen along with the blood plasma. This is accomplished by repeated washings and back washings.
  • 12-micron pore filters are preferred, it is possible to use filters in the range of 5-12 microns. When filters of 5 - 8 micron size are used, 7-micron red blood cells and 12-micron white blood cells can still be forced through the filters by pressure.
  • This same container which now contains only the cells of clinical interest is then subjected to the approximately 18 Pap solutions which are generally sequentially introduced into the container in an amount to fill the same, then removed until the final cells are stained in accordance with the Pap process, after which the cells are evenly deposited on a glass slide with our without a filter.
  • the washings and Pap solutions used according to the present invention cannot result in either the loss of cells of clinical interest or the contamination of the cells in the container by another patient's cells.
  • cells of clinical interest cannot get in or out of the container and other cells cannot get into the container.
  • the time required for contact of the cells with the various Pap solutions is substantially reduced as compared to proceeding in accordance with the normal Pap procedure because the cells are in suspension rather than being flat on a slide. Furthermore, the amount of solution is greatly reduced since only a few ml of solution are required to fill the container.
  • the tampon used during menstrual flow after removal from the woman, is placed in a vial containing fixative solution.
  • the vial is sealed and transported to the laboratory.
  • the vial is shaken, inverted, swirled, or mildly sonicated to move cells from the tampon into the fixative solution and to create a cell suspension in the fixative solution.
  • the tampon may be removed and discarded, alternatively the vial's reciprocal cap may be punctured and the cell suspension extracted from the vial, following which the vial containing the tampon may be discarded.
  • the cell suspension is poured into a disposable plastic syringe with a filter holder containing a 5-12 micron pore filter, preferably a 12 micron pore filter.
  • the cells are washed and back washed by passing solutions through the filter until the blood and mucous have been removed. After the last washing, the cells are subjected to the standard Pap solutions, left on the filter and the filter is clipped to a glass slide and analyzed by the cytologist.
  • Each of the tampons is inserted into a separate vial containing a fixative solution and the vials are placed into machines which mildly sonicate the same to move cells from the tampon into the fixative solution and to create a cell suspension I the fixative solution.
  • the cell suspension is aspirated by the machine into a modified disposable plastic syringe with a filter holder containing 12 micron filter. The vial and tampon are removed and discarded by the machine.
  • the machine automatically works the modified disposable plastic syringe to wash and backwash the cells until the blood and mucous have been removed.
  • the machine then automatically moves the modified disposable plastic syringe to expose the cells sequentially to each and all of the solutions used in the standard Pap method. This can be done either by moving the syringe to each solution in turn, or by moving each solution in turn to the syringe. In either case, a solution is used once and then sent to drain.
  • the machine can either place the filter on a glass slide or centrifuge the cells onto a glass slide. In either case, the cells are ready to be read by the cytologist without ever having been touched by any hands, completely automatically.
  • the cell suspension after the standard Pap Test has been completed is introduced into a currently commercially available cell counter/sorter (laser microscope) which reads the cells, separates abnormal and suspicious cells, and puts them on a slide for the cytologist.
  • the machine also prints out a report. This possibility does not exist in the case of the ordinary Pap smear test because it is not possible by such test to obtain a sufficient number of cells in suspensions. This is only possible with the collection of menstrual blood by a tampon or the like and by proceeding as set forth herein.
  • Figure 1 is a schematic illustration of a device according to the invention in which a vial or cylinder is provided with a single filter;
  • Figure 2 is schematic illustration of another embodiment of the invention in which a vial or cylinder is provided with two filters;
  • Figure 3 is a schematic illustration of a device for sonicating specimens in the original collection container
  • Figure 4 is a schematic illustration of a device wherein liquids used in processing the cells are controlled by valves.
  • Figure 1 illustrates a cylinder 10 provided with a filter 12 at one end thereof so that treating liquid may be introduced through the filter and discharged through the same filter.
  • the filter 12 is held by filter holder ring 14.
  • the treating liquid is alternately driven in and out of the cylinder 10 through the filter 12 by means of pressure/vacuum pump 16 with control by means of solenoid valve 18.
  • the cylinder 10 is provided with two filters 12, one at each end of the cylinder, each held by a filter holder ring 14.
  • Pump 16 provides suction for drawing the treating liquid in one direction through the filters 12, with valves 18 opening and closing as needed.
  • a collection container 20 containing the specimen 22 is sonicated by means of sonicator 24 to move the cells into suspension in the treating liquid.
  • sonicator 24 By means of aspirator 26 and pump 28 the liquid 22 containing the suspended cells is aspirated, with the aid of pump 28 into cylinder 30 provided with a filter 32 which is held by filter holder ring 34.
  • the thus aspirated suspended specimen is then subjected to treatment with the Pap solutions.
  • reservoirs 36A, 36B, 36C, etc., each containing a different Pap solution used in the Pap method is alternately supplied by means of control valves 38 and 40 to the cylinder for treatment of the cells therein.
  • Each liquid, alcohol, stain, etc. is passed into the cylinder and then withdrawn from the cylinder.
  • Supply 42 illustrates the possibility of various treating solutions entering the system from a different entrance.
  • the tampon after removal from the woman is placed into a vial containing a fixative solution.
  • the fixative is used in cytology to maintain the existing form and structure of the cells, particularly the nuclear detail.
  • the fixative solution may be, for example, 10% neutral buffered formalin or dilute methyl or ethyl alcohol, or it may be a mixture of alcohol and wax, which forms a thin, protective coating over the cells and preserves the same until they are processed in the cytology laboratory.
  • the vial containing the tampon in the fixative solution is shaken or sonicated to create a cell suspension in the solution.
  • the tampon is removed and discarded, alternatively the vial's reciprocal cap may be punctured and the cell suspension extracted from the vial, following which the vial containing the tampon may be discarded.
  • the cell suspension is introduced into the disposable plastic syringe provided with a filter holder containing a 5 - 12 micron filter, preferably 12-micron filter.
  • the cells are washed and backwashed until blood and mucous have been removed leaving only the cells of clinical interest on the filter.
  • These cells are then subjected to the Pap stain solutions for visualization of cellular changes.
  • the stain is basically composed of a blue nucleus stain and orange, red and green cytoplasmic counter stains.
  • the nuclear stain demonstrates the chromatin patterns associated with normal and abnormal cells, while the cytoplasmic stains help to indicate cell origin.
  • the cells are generally subjected to about 18 or more different staining solutions, after which the filter is placed up on a glass slide or the cells, are centrifuged onto the glass slide, after which the cytologist can read the slide.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

L'invention concerne un procédé d'analyse d'écoulement menstruel récupéré dans un tampon ou analogue, lequel sang comprendrait des cellules d'intérêt clinique. Le sang est déposé dans un contenant (10) comportant un filtre (12) ayant une dimension de pore telle que toutes les cellules d'intérêt clinique dans l'échantillon de sang ne peuvent pas passer à travers le filtre, tandis que les cellules qui ne sont pas d'intérêt clinique, par exemple les globules rouges et les globules blancs, sont assez petites pour passer à travers le filtre (12), soumettant lesdites cellules de sang menstruel dans le contenant à des lavages et à des relavages, et soumettant en outre les cellules à approximativement 18 solutions de test Pap, après quoi les cellules restant dans le contenant (10) peuvent être déposées sur une lamelle de verre et analysées par un cytologiste. L'invention s'étend également au dispositif utilisé dans l'analyse Pap.
PCT/ZA2012/000014 2011-07-22 2012-03-07 Dispositif et procédé pour une analyse rapide et précise de fluides corporels Ceased WO2013016743A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA2011/05403 2011-07-22
ZA2011/05403A ZA201105403B (en) 2010-07-20 2011-07-22 Device and method for rapid and accurate bodily fluid analysis

Publications (1)

Publication Number Publication Date
WO2013016743A1 true WO2013016743A1 (fr) 2013-01-31

Family

ID=47601587

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ZA2012/000014 Ceased WO2013016743A1 (fr) 2011-07-22 2012-03-07 Dispositif et procédé pour une analyse rapide et précise de fluides corporels

Country Status (1)

Country Link
WO (1) WO2013016743A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111826270A (zh) * 2019-04-22 2020-10-27 任玉波 一种便捷收集大量体液中脱落细胞的装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0483506B1 (fr) * 1990-09-25 1997-07-30 Microbyx Corporation Méthode et appareil pour essai de pap automatisé

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0483506B1 (fr) * 1990-09-25 1997-07-30 Microbyx Corporation Méthode et appareil pour essai de pap automatisé

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111826270A (zh) * 2019-04-22 2020-10-27 任玉波 一种便捷收集大量体液中脱落细胞的装置

Similar Documents

Publication Publication Date Title
EP0654972B1 (fr) Procede et appareil permettant d'obtenir des monocouches cytologiques
EP0535212B1 (fr) Recipient a enchantillons de liquide et ses modules de test
US5139031A (en) Method and device for cytology and microbiological testing
TW319694B (fr)
JP4074058B2 (ja) 流体試料と粒子物質を混合および流体試料から粒子物質を分離をする方法、およびその装置
EP2694942B1 (fr) Procédé pour préparer des échantillons cytologiques pour des analyses
EP3351921A1 (fr) Support de substrat de support de cellules pour préparer un échantillon d'observation, ensemble comprenant celui-ci, et procédé de préparation d'échantillon d'observation
CN214952520U (zh) 循环肿瘤细胞苏木素-伊红染色装置以及苏木素-伊红染色和微量核酸提取、浓缩装置
US20140127745A1 (en) Method, compositions and device for preparing cytological specimens
EP0483506B1 (fr) Méthode et appareil pour essai de pap automatisé
CN113358445A (zh) 一种液基细胞的悬浮染色方法
US6830935B1 (en) Method for mixing and processing specimen samples
EP1093572B1 (fr) Procede ameliore de melange et de traitement d'echantillons
JPH06194282A (ja) 細胞学的材料の単層の調製法
US20160202278A1 (en) Automatic method and automated device for processing a plurality of cell suspensions
EP2167642A1 (fr) Procédé de séparation d'objets biologiques par rapport à leurs propriétés viscoélastiques
US8911686B2 (en) Separation device
US9440234B2 (en) Device for analysis of a target analyte
Balassanianb Cell blocks: evolution, modernization, and assimilation into emerging technologies
CN117795311A (zh) 制备用于分析或诊断目的的生物样本的设备和方法
JP6671681B2 (ja) 検鏡標本の作製方法
CA3149235A1 (fr) Dispositif d'immobilisation de cellules rares pour la cytologie
Rowe et al. PREPmate automated processor: Comparison of automated and manual methods of liquid‐based gynecologic sample preparation
WO2024224428A2 (fr) Tampons prêts à l'emploi pour la coloration et la fixation de lames de sang périphérique
CN114993788A (zh) 一种宫颈液基细胞学项目质控品及其制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12817039

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12817039

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 28/08/2014)